/stocks — the workspaceLOADING
Jazz Pharmaceuticals plc (JAZZ) is a pharmaceutical preparations company. Piotroski F-Score 5/8. 16 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-04 from JAZZ's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
A plain-English read on JAZZ plus an auto-SWOT — built from JAZZ's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate JAZZ using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| COZADD BRUCE CDirector | SELL | $1.4M | view → |
| Smith Mark DouglasDirector | SELL | $267K | view → |
| Patil Neena MEVP & Chief Legal Officer | SELL | $278K | view → |
| COZADD BRUCE CDirector | SELL | $1.4M | view → |
| Pearce SamanthaEVP, Chief Commercial Officer | SELL | $1.6M | view → |
| Patil Neena MEVP & Chief Legal Officer | SELL | $282K | view → |
| McSharry Heather AnnDirector | SELL | $482K | view → |
| Winningham Rick EDirector | SELL | $662K | view → |
| Tweedy Browne | $11.4M | 0.9% of portfolio |
Projected from JAZZ's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment JAZZ files its announcement.
JAZZ has rallied after 5 of its last 8 earnings reports.
Large earnings reactions have been common.
JAZZ has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+13.6% and -14.2%).
A more typical earnings reaction has been approximately ±7.1%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-05 | +9.9% |
| 2026-02-24 | +13.6% |
| 2026-01-12 | +0.8% |
| 2025-11-05 | -2.7% |
| 2025-08-05 | -8.8% |
| 2025-05-06 | -14.2% |
| 2025-02-25 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +5.5% |
| 2025-01-13 | +1.3% |